FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on

US FDA approves Regeneron’s ultra-rare blood disease drug

FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown

FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid/File Photo

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Copyright © 2024 Active Trader Daily - Succinct Financial News.
Copyright © 2024 Active Trader Daily - Succinct Financial News.